Ichthammol
Showing 1 - 25 of 66
Glioblastoma, Malignant Glioma Trial in Duarte (Azeliragon, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Glioblastoma
- Malignant Glioma
- Azeliragon
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 6, 2023
Advanced Malignant Tumor, Cancer Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)
Recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Dexamethasone
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 3, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Dexamethasone, Isatuximab)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Abatacept
- +3 more
-
Buffalo, New York
- +2 more
Dec 22, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)
Recruiting
- Plasma Cell Myeloma
- Belantamab Mafodotin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Jul 21, 2022
Low Grade Glioma, Malignant Brain Glioma, Malignant Brain Tumor Trial in Atlanta (procedure, drug, other)
Not yet recruiting
- Low Grade Glioma
- +3 more
- Biospecimen Collection
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Nov 7, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee
Recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Aug 1, 2022
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester
Recruiting
- Plasma Cell Myeloma
- +3 more
- Bone Marrow Biopsy
- +3 more
-
Phoenix, Arizona
- +2 more
Jan 18, 2023
Multiple Myeloma Trial in Rochester (procedure, biological, drug)
Not yet recruiting
- Multiple Myeloma
- Biospecimen Collection
- +12 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 15, 2023
Malignant Brain Tumor, Metastatic Malignant Tumor in the Brain, Recurrent Malignant Brain Tumor Trial in Duarte (Dexamethasone)
Recruiting
- Malignant Brain Neoplasm
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 3, 2022
Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,
Recruiting
- Recurrent AL Amyloidosis
- Refractory AL Amyloidosis
- Biospecimen Collection
- +9 more
-
Duarte, California
- +10 more
Jan 19, 2023
Plasma Cell Myeloma Trial in Rochester (biological, drug, other)
Active, not recruiting
- Plasma Cell Myeloma
- Daratumumab
- +5 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2022
Recurrent Plasma Cell Myeloma Trial in United States (Daratumumab, Dexamethasone, Pomalidomide)
Withdrawn
- Recurrent Plasma Cell Myeloma
- Daratumumab
- +2 more
-
Wichita, Kansas
- +4 more
Jun 13, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Dexamethasone, Leflunomide, Pomalidomide)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Dexamethasone
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 10, 2022
Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)
Recruiting
- Recurrent Non-Small Cell Lung Carcinoma
- +3 more
- Dexamethasone
- +3 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)
Recruiting
- Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Biospecimen Collection
- +9 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 1, 2023
Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +3 more
- Decitabine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)
Not yet recruiting
- ISS Stage III Plasma Cell Myeloma
- Plasma Cell Myeloma
- Bone Marrow Aspiration and Biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 9, 2022
Recurrent Plasma Cell Myeloma Trial in Rochester (drug, other, biological)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Dexamethasone
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
May 19, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +4 more
-
Des Moines, Iowa
- +8 more
Jan 12, 2023
Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)
Recruiting
- Plasma Cell Myeloma
- Renal Failure
- Bortezomib
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 13, 2022